Japanese Knotweed Group Ltd is a specialist invasive-plant services company that delivers Japanese knotweed identification, on-site surveys, and structured treatment plans for residential and commercial properties across the south of England. The business sells a defined survey product (£250+VAT) that includes a detailed written report, extensive photographic evidence (20 images), mapping, and measured site observations covering gardens, beds, boundary lines, and neighbouring fence lines. It then converts survey findings into longer-term management through a 5-year interest-free treatment plan and a 10-year insurance-backed guarantee, positioning its service as mortgage- and conveyancing-ready risk control rather than simple gardening work. The company differentiates through speed (next-day paperwork), formal documentation, and an emphasis on professional removal and safe disposal to protect property value and prevent structural impact. Its model centres on rapid surveying and reporting, followed by multi-year remediation programmes that provide reassurance to buyers, sellers, and property owners.

The primary audience is property owners and buyers in London and the surrounding counties—Surrey, Kent, Essex, West Sussex, and Hampshire—who need fast, formal confirmation of knotweed presence or absence. It also targets property managers, landlords, and business owners responsible for site compliance, asset protection, and maintaining property value. Customers are motivated by risk avoidance: preventing structural damage, avoiding mortgage/conveyancing delays, and stopping costly disputes tied to undisclosed infestation (“miss-sold” properties). The audience ranges from first-time homeowners with low technical knowledge of invasive species to experienced property professionals who require documentation that stands up in transactions and claims. They choose this business for rapid turnaround (next-day paperwork), comprehensive reporting evidence (photos, maps, measurements), and the added confidence of a 10-year insurance-backed guarantee tied to longer-term treatment.